Manual of U.S. Patent Classification
as of June 30, 2000

Class
530
CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF

Class definitions may be accessed by clicking on the class title, above.
Subclass definitions may be accessed by clicking on the subclass number, below.

Patents classified in a subclass may be accessed by clicking on the " " icon following the subclass number, below.

( please note that links to definitions and classified patents may not be available for some classes and subclasses )

For search strategies, please refer to the Classification Index Explanation of Data web page.

Subclass		Title
ClassTitle		===> CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF
		This Class 530 is considered to be an integral part of Class 260 (see the Class 260 schedule for the position of this Class in schedule hierarchy). This Class retains all pertinent definitions and class lines of Class 260.
200		NATURAL RESINS OR DERIVATIVES (E.G., WOOD OR PINE TAR; CATIVO RESIN DERIVATIVES, ETC.)
201		. Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.)
202		. Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material)
203		. Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material)
204		. . Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material)
205		. Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.)
206		. . Organic sulfur or nitrogen containing material used in the process, or product thereof
207		. . Esterification used in the process, or product thereof
208		. . Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.)
209		. . . Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof
210		. Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.)
211		. . Polymerization or product thereof (e.g., dimer rosin, etc.)
212		. . . Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.)
213		. . Boron or phosphorus containing material used in the process, or product thereof
214		. . Diels-Alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.)
215		. . Esterification of rosin or derivative via carboxyl group, or product thereof
216		. . . Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.)
217		. . . Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.)
218		. . . Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.)
219		. . Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.)
220		. . . The sulfur, selenium, or tellurium containing material is inorganic
221		. . Nitrogen containing material used in the process, or product thereof
222		. . . The nitrogen containing material is inorganic
223		. . Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.)
224		. . Metal containing material used to form salts of rosin acids, or product thereof
225		. . . Alkali metal containing material (i.e., Li, Na, K, Rb or Cs)
226		. . Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.)
227		. . . Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.)
228		. . Purification process or product thereof
229		. . . Immiscible solvents used in the process, or product thereof
230		. Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.)
231		. . Nitrogen containing material used in the process, or product thereof
232		. . Esterification of tall oil acids, or product thereof
233		. . Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof
300		PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES
301		. Thymopoietin or Lipotropin; related peptides
302		. Endorphin and Enkephalin; related peptides
303		. Insulin; related peptides
304		. . Metal complexes, e.g., Zn-insulin, etc.
305		. . Isolation or purification
306		. Corticotropin (ATCH); related peptides
307		. Calcitonin; related peptides
308		. Glucagon; related peptides
309		. Secretin or gastrin; related peptides
310		. Gramicidin or Tyrocidin; related peptides
311		. Somatostatin (SRIF); related peptides
312		. Melanotropin (MSH) or eledoisin; related peptides
313		. Lutenizing hormone releasing factor (LRF); related peptides
314		. Bradykinin; kallidin; related peptides
315		. Oxytocin; vasopressin; related peptides
316		. Angiotensin; related peptides
317		. Cyclic peptides
318		. . The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid
319		. . . Polymyxin; related peptides
320		. . Bacitracin; related peptides
321		. . Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides
322		. Peptides containing saccharide radicals, e.g., bleomycins, etc.
323		. Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc.
324		. 25 or more amino acid residues in defined sequence
325		. 24 amino acid residues in defined sequence
326		. 15 to 23 amino acid residues in defined sequence
327		. 11 to 14 amino acid residues in defined sequence
328		. 8 to 10 amino acid residues in defined sequence
329		. 6 to 7 amino acid residues in defined sequence
330		. 4 to 5 amino acid residues in defined sequence
331		. Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc.
332		. Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc.
333		. Synthesis of peptides
334		. . Polymer supported synthesis, e.g., solid phase synthesis, Merrifield synthesis, etc.
335		. . Protecting or removing protective groups, e.g., carboxyl group protection, etc.
336		. . . Of side chain or sulfur containing group
337		. . . Of amino group
338		. . Solution phase synthesis
339		. . . Segment condensation, e.g., Ugi condensation, etc.
340		. . . With phosphorus containing material
341		. . . With use of carbonimide or imidiazole
342		. . . Mixed anhydride synthesis
343		. . By hydrolysis
344		. Separation or purification
345		. Chemical aftertreatment, e.g., acylation, methylation, etc.
350		PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES
351		. Lymphokines, e.g., interferons, interlukins, etc.
352		. Phosphoproteins, e.g., phosvitin, vitellogenin, etc.
353		. Scleroproteins, e.g., fibroin, elastin, silk, etc.
354		. . Gelatin
355		. . . Separation, purification or synthesis
356		. . Collagen
357		. . Keratin
358		. Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc.
359		. Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.
360		. Casein or caseinate
361		. . Separation, purification or synthesis
362		. Albumin
363		. . Serum albumin, e.g., BSA, HSA, etc.
364		. . . Separation, purification or synthesis
365		. . Lactalbumin, e.g., milk source, etc.
366		. . . Separation, purification or synthesis
367		. . Ovalalbumin, e.g., avidin, conalbumins, etc.
368		. . . Separation, purification or synthesis
369		. . Separation, purification or synthesis
370		. Plant proteins, e.g., derived from legumes, algae or lichens, etc.
371		. . Derived from fungi, e.g., yeasts, mushroom, etc.
372		. . Derived from grain, e.g., prolamines, etc.
373		. . . Zein
374		. . . Gluten or gliadin
375		. . . Derived from wheat
376		. . . Derived from corn
377		. . Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc.
378		. . . Derived from soybean
379		. . Derived from leafy green plants, e.g., alfalfa pollen, etc.
380		. Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.
381		. . Blood coagulation factors and fibrin, e.g., thromboplastin, etc.
382		. . . Fibrin or fibrin intermediates, e.g., fibrinogen, etc.
383		. . . Blood coagulation factor VIII, AHF
384		. . . Blood coagulation factor II or factor II + VII + IX + X, i.e., prothrombin complex or factor
385		. . Hemoglobins or globins
386		. . Globulins
387.1		. . . Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed
387.2		. . . . Anti-idiotypic
387.3		. . . . Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.)
387.5		. . . . Binds oligosaccharide structure
387.7		. . . . Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)
387.9		. . . . Binds specifically-identified amino acid sequence
388.1		. . . . Monoclonal
388.15		. . . . . Human
388.2		. . . . . Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)
388.21		. . . . . . Binds nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.)
388.22		. . . . . . Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)
388.23		. . . . . . Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)
388.24		. . . . . . Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.)
388.25		. . . . . . Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)
388.26		. . . . . . Binds enzyme
388.3		. . . . . . Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)
388.35		. . . . . . . Binds retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.)
388.4		. . . . . . Binds bacterium or similar microorganism or component or product thereof (e.g., Stretococcus, Legionella, Mycoplasma, bacterium-associated antigen, exotoxin, etc.)
388.5		. . . . . . Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.)
388.6		. . . . . . Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.)
388.7		. . . . . . Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)
388.73		. . . . . . . Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.)
388.75		. . . . . . . . Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.)
388.8		. . . . . . Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)
388.85		. . . . . . . Binds antigen characterized by name or molecular weight (e.g., CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.)
388.9		. . . . . Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)
389.1		. . . . Polyclonal antibody or immunogloblin of identified binding specificity
389.2		. . . . . Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)
389.3		. . . . . Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)
389.4		. . . . . Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)
389.5		. . . . . Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.)
389.6		. . . . . Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.)
389.7		. . . . . Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)
389.8		. . . . . Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)
390.1		. . . . Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.)
390.5		. . . . Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)
391.1		. . . Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.)
391.3		. . . . Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound
391.5		. . . . . Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent
391.7		. . . . Conjugated to a cytotoxic agent, drug, or other biologically-active substance
391.9		. . . . . Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent
392		. . . Alpha globulins, e.g., ceruloplastin, haptoglobins, etc.
393		. . . . Antithrombin III
394		. . . Beta globulins, e.g., transferrin, etc.
395		. Glycoprotein, e.g., mucins proteoglycans, etc.
396		. . Lectins, e.g., concanavalin, hemagglutinin, etc.
397		. . Glycoprotein hormones
398		. . . Gonadatropins
399		. Hormones, e.g., prolactin, thymosin, growth factors, etc.
400		. Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc.
401		. . Cytochromes, e.g., chlorophyl, orgotein, etc.
402		. Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.
403		. . Protein is identified as an antigen, e.g., immunogenic carriers, etc.
404		. . . Sulfur containing reactant
405		. . . Nitrogen containing reactant
406		. . . Oxygen containing reactant
407		. . Hydrolysis of protein
408		. . Sulfur containing reactant
409		. . Nitrogen containing reactant
410		. . Oxygen containing reactant
411		. . . Oxygen containing is saccharide
412		. Separation or purification
413		. . Immunological separation or affinity chromatography
414		. . Ultra filtration or osmosis
415		. . Selective absorbtion, e.g., Ca phosphate sorbents, etc.
416		. . . Ion exchange
417		. . . Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.
418		. . Precipitation
419		. . . With added material
420		. . . . Inorganic
421		. . . . Polymeric, e.g., polyethylene glycol, etc.
422		. . Solvent extraction
423		. . . Oxygenated material
424		. . . . Alcohol
425		. . . . Carboxyl containing
426		. . . Hydrocarbon or halogenated hydrocarbon
427		. . Physical treatment
500		LIGNINS OR DERIVATIVES
501		. Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof
502		. Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof
503		. Hydrogenation of a lignin or lignin containing substance, or product thereof
504		. Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof
505		. Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof
506		. Heavy metal, aluminum, silicon or phosphorus containing
507		. Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof
		******************************
		CROSS-REFERENCE ART COLLECTIONS
		******************************
800		ANTIHYPERTENSIVE PEPTIDES
801		PEPTIDE SWEETNERS
802		CHROMOGENIC OR LUMINESCENT PEPTIDES
806		ANTIGENIC PEPTIDES OR PROTEINS
807		HAPTEN CONJUGATED WITH PEPTIDE OR PROTEIN
808		MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC.
809		. Fused cells, e.g., hybridoma, etc.
810		CARRIER - BOUND OR IMMOBILIZED PEPTIDES OR PROTEINS AND THE PREPARATION THEREOF, E.G., BIOLOGICAL CELL OR CELL FRAGMENT AS CARRIER, ETC.
811		. Peptides or proteins is immobilized on, or in, an inorganic carrier
812		. Peptides or proteins is immobilized on, or in, an organic carrier
813		. . Carrier is a saccharide
814		. . . Cellulose or derivatives thereof
815		. . Carrier is a synthetic polymer
816		. . . Attached to the carrier via a bridging agent
817		. . . Entrapped within the carrier, e.g., gel, hollow fibre, etc.
820		PROTEINS FROM MICRO-ORGANISMS
821		. Separation of nucleic acid
822		. Protozoa
823		. Lower fungi, e.g., mold, etc.
824		. . Yeasts
825		. Bacteria
826		. Viruses
827		PROTEINS FROM MAMMALS OR BIRDS
828		. Cancer
829		. Blood
830		. . Plasma; serum
831		. . . Cohn fractions
832		. Milk; colostrum
833		. Whey; cheese
834		. Urine; urinary system
835		. . Kidney
836		. Mucus; mucous glands; bursa; arthral fluid; spinal fluid
837		. Lymph; lymph-glands; thymus
838		. Marrow; spleen
839		. Nerves; brain
840		. Bones; tendons; teeth; cartilage
841		. Muscles; heart
842		. Skin; hair; nails; sebaceous glands; cerumen
843		. Digestive system
844		. . Stomach; intestine
845		. . Pancreas
846		. . Liver
847		. . Bile
848		. Lungs
849		. Eyes; vessels; umbilical cord
850		. Reproductive organs or embryos
851		. . Placenta; amniotic fluid
852		. . Sperm
853		. . . Ovary; eggs; embryos
854		. Glands
855		PROTEINS FROM ANIMALS OTHER THAN MAMMALS OR BIRDS
856		. Snakes; venom
857		. Fish; fish eggs; shell fish; crustacea
858		. Insects; venom
859		WASTE, WASTE MATERIAL, REFUSE OR SLUDGE, E.G., EFFLUENTS, FECAL MATTER, ETC.
860		RENIN INHIBITORS
861		INVOLVING IgG3, IgG4, IgA, or IgY
862		INVOLVING IgE or IgD
863		INVOLVING IgM
864		. Monoclonal
865		. . Human
866		INVOLVING IMMUNOGLOBULIN OR ANTIBODY FRAGMENT, (e.g., F(ab)'2, Fab', Fab, Fv, Fc, heavy chain, light chain, etc.)
867		INVOLVING IMMUNOGLOBULIN OR ANTIBODY PRODUCED VIA RECOMBINANT DNA TECHNOLOGY
868		INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCE

Information Products Division -- Contacts

Questions regarding this report should be directed to:

U.S. Patent and Trademark Office
Information Products Division
PK3- Suite 441
Washington, DC 20231

tel: (703) 306-2600
FAX: (703) 306-2737
email: oeip@uspto.gov

---

Last Modified: 6 October 2000